INI-2004

DRUG2 trials

Sponsors

Inimmune Corporation

Conditions

Allergic RhinitisAllergic Rhinitis Due to AllergensAllergic Rhinitis Due to Weed PollenRhinitis Allergic

Phase 1

Trial of INI-2004 in Healthy Volunteers and Participants With Allergic Rhinitis.

CompletedNCT06038279

Inimmune CorporationAllergic Rhinitis, Allergic Rhinitis Due to Weed Pollen

Start: 2023-07-04End: 2024-09-05Updated: 2026-01-16

Phase 2

Environmental Exposure Unit Trial in Subjects With Ragweed-induced Allergic Rhinitis

CompletedNCT07556393

Inimmune CorporationAllergic Rhinitis, Allergic Rhinitis Due to Allergens, Rhinitis Allergic

Start: 2026-01-19End: 2026-04-23Updated: 2026-04-29